Articoli correlati a When Progress Fails to Materialize: When new cancer...
When Progress Fails to Materialize: When new cancer drugs become available and who receives them - Brossura
Risultati della ricerca per When Progress Fails to Materialize: When new cancer...
Foto dell'editore
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Da: California Books, Miami, FL, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: New. Codice articolo I-9783691733884
Compra nuovo
EUR 25,71
Spedizione gratuita
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
When Progress Fails to Materialize
Da: Rarewaves.com USA, London, LONDO, Regno Unito
Valutazione del venditore 5 su 5 stelle
Paperback. Condizione: New. Codice articolo LU-9783691733884
Compra nuovo
EUR 26,42
Spedizione gratuita
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
When Progress Fails to Materialize
Da: PBShop.store US, Wood Dale, IL, U.S.A.
Valutazione del venditore 5 su 5 stelle
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000. Codice articolo L2-9783691733884
Compra nuovo
EUR 27,16
Spedizione gratuita
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
When Progress Fails to Materialize
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
Valutazione del venditore 5 su 5 stelle
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000. Codice articolo L2-9783691733884
Compra nuovo
EUR 25,83
Spedizione EUR 3,88
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: Più di 20 disponibili
Foto dell'editore
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Print on DemandDa: Majestic Books, Hounslow, Regno Unito
Valutazione del venditore 4 su 5 stelle
Condizione: New. Print on Demand. Codice articolo 408252279
Compra nuovo
EUR 31,47
Spedizione EUR 7,66
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: 4 disponibili
Foto dell'editore
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Print on DemandDa: Books Puddle, Woodside, NY, U.S.A.
Valutazione del venditore 4 su 5 stelle
Condizione: New. Print on Demand. Codice articolo 26404934824
Compra nuovo
EUR 36,93
Spedizione EUR 3,56
Spedito in U.S.A.
Spedito in U.S.A.
Quantità: 4 disponibili
Foto dell'editore
When Progress Fails to Materialize: When new cancer drugs become available and who receives them
Print on DemandDa: Biblios, Frankfurt am main, HESSE, Germania
Valutazione del venditore 4 su 5 stelle
Condizione: New. PRINT ON DEMAND. Codice articolo 18404934818
Compra nuovo
EUR 31,60
Spedizione EUR 9,95
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 4 disponibili
Foto dell'editore
When Progress Fails to Materialize
Editore:
Bremen University Press Sep 2025, 2025
ISBN 10: 3691733883
ISBN 13: 9783691733884
Nuovo
Taschenbuch
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 116 pp. Englisch. Codice articolo 9783691733884
Compra nuovo
EUR 20,00
Spedizione EUR 23,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 2 disponibili
Foto dell'editore
When Progress Fails to Materialize (Paperback)
Print on DemandDa: CitiRetail, Stevenage, Regno Unito
Valutazione del venditore 5 su 5 stelle
Paperback. Condizione: new. Paperback. This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available. It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies. The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today. Bremen University Press has published over 5,000 specialist books in various languages since 2005. September 2025 This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Codice articolo 9783691733884
Compra nuovo
EUR 29,72
Spedizione EUR 43,60
Spedito da Regno Unito a U.S.A.
Spedito da Regno Unito a U.S.A.
Quantità: 1 disponibili
Immagini fornite dal venditore
When Progress Fails to Materialize
Editore:
Bremen University Press Sep 2025, 2025
ISBN 10: 3691733883
ISBN 13: 9783691733884
Nuovo
Taschenbuch
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book combines two crucial perspectives: it shows how the development of modern cancer drugs-from immunotherapies and RNA approaches to genetic methods such as CRISPR-will unfold over the next five, ten, and twenty years. At the same time, it asks who will actually have access to these innovations when they become available.It highlights the scientific paths from discovery to approval, the opportunities and limitations of accelerated procedures, the economic and social hurdles, and the profound ethical questions associated with the distribution of high-priced therapies. An international comparison of healthcare systems shows that progress is not equally distributed - while wealthy countries struggle with prices and budgets, the majority of the world's population remains excluded from state-of-the-art therapies.The book brings both strands together and makes it clear that the future of oncology will be decided not only in the laboratory, but also in insurance companies, political institutions, and the values of modern societies. In many cases, cancer could become a chronically controllable disease in the coming decades - whether this will be a collective advance for all or an exclusive privilege for the few depends on decisions that must be made today.Bremen University Press has published over 5,000 specialist books in various languages since 2005.September 2025Books on Demand GmbH, Überseering 33, 22297 Hamburg 116 pp. Englisch. Codice articolo 9783691733884
Compra nuovo
EUR 20,00
Spedizione EUR 60,00
Spedito da Germania a U.S.A.
Spedito da Germania a U.S.A.
Quantità: 1 disponibili